Related Experiment Videos

Radiologic long-term results after cervical vertebral interbody fusion with polymethyl methacrylat (PMMA)

D K Böker1, R Schultheiss, E M Probst

  • 1Department of Neurosurgery, University of Bonn, West Germany.

Neurosurgical Review
|January 1, 1989
PubMed

Insights

Long-term cervical interbody fusion with polymethyl methacrylate (PMMA) shows excellent results. This study found PMMA is engrafted in about 2 years, achieving stable fusion in 90% of patients with no observed malignoma.

Area of Science:

  • Orthopedics
  • Spinal Surgery
  • Biomaterials

Background:

  • Cervical interbody fusion is a common surgical procedure.
  • Polymethyl methacrylate (PMMA) has been used as a bone graft substitute.
  • Long-term outcomes of PMMA in cervical fusion require further evaluation.

Purpose of the Study:

  • To evaluate the long-term efficacy and safety of cervical interbody fusion using PMMA.
  • To assess bone engraftment, fusion stability, and potential complications.

Main Methods:

  • Retrospective study of 83 patients undergoing cervical interbody fusion with PMMA.
  • Radiographic assessment of bone engraftment and fusion stability.
  • Long-term follow-up ranging from 15 to 20 years post-operation.

Main Results:

  • Polymethyl methacrylate (PMMA) demonstrated engraftment by approximately 2 years post-surgery.
  • Stable vertebral interbody fusion was achieved in about 90% of the evaluated cases.
  • No instances of malignoma development were observed; resorptive bone alterations were non-progressive and healed, occurring in only 2% of cases.

Conclusions:

  • Cervical interbody fusion with PMMA is a safe and effective long-term solution.
  • PMMA provides stable fusion and does not increase the risk of malignancy.
  • Observed bone alterations are transient and do not compromise fusion stability.

Related Concept Videos